As trade policy, regulatory scrutiny, and capital discipline reshape biologics development, sponsors are rethinking where and ...
Analyst Insight: Capacity constraints are emerging as a critical barrier to growth in today’s volatile market. Consumer goods manufacturers are deploying advanced capacity modeling, strategic ...
ROIS adds a US sterile fill-finish hub, enabling lifecycle continuity from European development to US commercial supply within one CDMO network. The Phoenix facility supports vials, prefilled syringes ...